Oncolytics Biotech Inc T.ONC

Volume

[venture009]

The most recent conference call was upbeat with management hinting of better things to come. However, the market has not bought into managements expectations. After 1.5 hours of trading May 9th, there is less than 1000 shares traded on Toronto and 19000 (38000/2) on NASDQ, which is a total lack of enthsiasm. As has been the case over the past decade or more there is a complete disconnect between what's coming from the offices of ONCY and reality. Will it be different this time? We can only hope but it the past predicts the future everyone should curb their enthusiasm until management finally delivers the goods.

[westcoast1000]

Venture, I agree with you that we will have to wait for a significant event that signals that management has delivered the goods before the price wil appreciate significantly. But that puts us all in a bind, because we need the price to go up to do a sensible deal. 

[venture009]

Westcoast, Management are certainly putting a lot of emphasis on ASCO so it better be good. Then we'll see how excited the market reaction is. As Geneman said if pela turns tumors from cold to hot then the price will look after itself. Otherwise the proverbal pin will hit the balloon once again.  ONCY's release today was another example of the management being able to convince the

[westcoast1000]

Yes, we are all waiting for the proverbial set of events that allows the price to take care of itself.